Pregabalin Single Dose for Preoperative Pediatric Sedation

Pregabalin Single Dose for Preoperative Pediatric Sedation - Pregabalin Preoperative Pediatric Sedation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022031

Enrollment

Registered

2016-05-01

Start date

2016-04-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preoperative Pediatric Sedation

Interventions

Group A will receive oral pregabalin 5mg/kg 60 min before induction and Group B receiving placebo 60min before induction

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: After approval of the local ethical committee of anesthesia department Menofia University and written informed consent from parents, sixty ASA state I-II children, whose age from 12: 16 or their weight over 30kg, and doing minor elective surgery will be included

Exclusion criteria

Exclusion criteria: The study will exclude patients who unable to take oral pills, those with a mood disorder, on psychiatric medications or with developmental delay. Obesity also one of exclusion if the child reaches 95%percentil for age, as well as allergic reaction to the study medication.

Design outcomes

Primary

Measure	Time frame
Pregabalin provides as a preoperative anxiolysis or sedation for the tagged patient and possible side effects.	—

Countries

Africa

Contacts

Public ContactKhaled Saad

Faculty of Medicine - Assiut University Pediatric Department

khaled.ali@med.au.edu.eg+20882368373

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026